THE FDA HAS APPROVED A DRUG AGAINST NIEMANN–PICK DISEASE, TYPE C
.
Article Editorial
doaj
Evidence of Oxytosis/Ferroptosis in Niemann-Pick Disease Type C. [PDF]
Sanchez KL +11 more
europepmc +1 more source
Impact of Organelle Transport Deficits on Mitophagy and Autophagy in Niemann-Pick Disease Type C. [PDF]
Liedtke M +3 more
europepmc +1 more source
Arimoclomol and levacetylleucine for the treatment of neurologic manifestations of Niemann-Pick disease type C: A therapeutics bulletin of the American College of Medical Genetics and Genomics (ACMG). [PDF]
Rodriguez-Gil JL +4 more
europepmc +1 more source
Experience of the NPC Brazil Network with a Comprehensive Program for the Screening and Diagnosis of Niemann-Pick Disease Type C. [PDF]
Kubaski F +15 more
europepmc +1 more source
Clinical characteristics and treatment outcomes in patients with Niemann-Pick disease type C (NP-C): a cross-sectional study. [PDF]
Karimzadeh P +7 more
europepmc +1 more source
Searching, Structural Determination, and Diagnostic Performance Evaluation of Biomarker Molecules for Niemann-Pick Disease Type C Using Liquid Chromatography/Tandem Mass Spectrometry. [PDF]
Maekawa M, Mano N.
europepmc +1 more source
Gene Expression Profile of the Cerebral Cortex of Niemann-Pick Disease Type C Mutant Mice. [PDF]
Servín-Muñoz IV +5 more
europepmc +1 more source
Involvement of the Choroid Plexus in the Pathogenesis of Niemann-Pick Disease Type C. [PDF]
Van Hoecke L +13 more
europepmc +1 more source
Implications of the choroid plexus in Niemann-Pick disease Type C neuropathogenesis. [PDF]
van Gool R +18 more
europepmc +1 more source

